Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Operating expenses:
Research and development	$ 5,323,953	$ 3,069,899	$ 9,831,737	$ 4,345,847
General and administrative	7,433,249	1,065,803	12,899,903	2,491,859
Total operating expenses	12,757,202	4,135,702	22,731,640	6,837,706
Loss from operations	(12,757,202)	(4,135,702)	(22,731,640)	(6,837,706)
Other (expenses) income:
Interest/investment income, net	404,004	13,110	811,657	29,049
Realized gain (loss) on short-term investments	12,810		(158,801)
Unrealized gain on short-term investments	1,221,947		287,027
Total other (expenses) income	1,638,761	13,110	939,883	29,049
Net loss	$ (11,118,441)	$ (4,122,592)	$ (21,791,757)	$ (6,808,657)
Loss per common share – basic and diluted (in Dollars per share)	$ (0.73)	$ (0.50)	$ (1.45)	$ (0.86)
Weighted average number of common shares outstanding – basic and diluted (in Shares)	15,323,051	8,251,253	15,030,641	7,882,422